Thermophilic biohydrogen production strategy using agro industrial wastes: Current update, challenges, and sustainable solutions.

Continuously increasing wastes management issues and the high demand of fuels to fulfill the current societal requirements is not satisfactory. In addition, severe environmental pollution caused by generated wastes and the massive consumption of fossil fuels are the main causes of global warming. In this scenario, production of hydrogen from organic wastes is a potential and one of the most feasible alternatives to resolve these issues. However, sensitivity of H2 production at higher temperature and lack of potential substrates are the main issues which are strongly associated with such kinds of biofuels. Therefore, the present review is targeted towards the evaluation and enhancement of thermophilic biohydrogen production using organic, cellulosic wastes as promising bioresources. This review discusses about the current status, development in the area of thermophilic biohydrogen production wherein organic wastes as key substrate are being employed. The combinations of suitable organic and cellulose rich substrates, thermo-tolerant microbes, high enzymes stability may support to enhance the biohydrogen production, significantly. Further, various factors which may significantly contribute to enhance biohydrogen production have been discussed thoroughly in reference to the thermophilic biohydrogen production technology. Additionally, existing obstacles such as unfavorable thermophilic biohydrogen pathways, inefficiency of thermophilic microbiomes, genetic modifications, enzymes stability have been discussed in context to the possible limitations of thermophilic biohydrogen production strategy. Structural and functional microbiome analysis, fermentation pathway modifications via genetic engineering and the application of nanotechnology to enhance the thermophilic biohydrogen production have been discussed as the future prospective.

Dexibuprofen nanocrystals with improved therapeutic performance: fabrication, characterization, in silico modeling, and in vivo evaluation.

BACKGROUND: The aim of this study was to prepare and evaluate the impact of polymers on fabricating stable dexibuprofen (Dexi) nanocrystals with enhanced therapeutic potential, using a low energy, anti-solvent precipitation method coupled with molecular modelling approach. METHODS: Dexi nanocrystals were prepared using antisolvent precipitation with syringe pump. Crystallinity of the processed Dexi particles was confirmed using differential scanning calorimetry and powdered X-ray diffraction and transmission electron microscopy. Dissolution of Dexi nanocrystals was compared with raw Dexi and marketed tablets. Molecular modelling study was coupled with experimental studies to rationalise the appropriate polymers for stable Dexi nanocrystals. Antinociceptive study was carried out using balb mice. RESULTS: Combinations of hydroxypropyl methylcellulose (HPMC)-polyvinyl pyrrolidone (PVP) and HPMC-Eudragit (EUD) were shown to be very effective in producing stable Dexi nanocrystals with particle sizes of 85.0±2.5 nm and 90±3.0 nm, and polydispersity of 0.179±0.01, 0.182±0.02, respectively. The stability studies conducted for 90 days demonstrated that nanocrystals stored at 2°C-8°C and 25°C were more stable than those at 40°C. The maximum recovery of Dexi nanocrystals was observed from the formulations using the combination of HPMC-PVP and HPMC-EUD, which equated to 98% and 94% of the nominal active drug content respectively. The saturation solubility of the Dexi nanocrystals was substantially increased to 270.0±3.5 µg/mL compared to the raw Dexi in water (51.0±2.0 µg/mL) and stabilizer solution (92.0±3.0 µg/mL). Enhanced dissolution rate (P<0.05) was observed for the Dexi nanocrystals compared to the unprocessed drug substance and marketed tablets. Dexi nanocrystals produced the analgesic effect at much lower doses (5 mg/kg) than that of control standard, diclofenac sodium (20 mg/kg) and Dexi counterparts (40 mg/kg). CONCLUSION: HPMC-PVP and HPMC-EUD were found the best polymer combination to stabilise Dexi nanocrystals. The Dexi nanocrystals exhibited significant dissolution, solubility and analgesic effect compared to the raw Dexi and the control standard diclofenac sodium.